[Equine strongyles. I. Development of anthelmintic resistance].

The research article is about the increased anthelmintic resistance of small strongyles (a type of parasite) in horses and emphasizes the importance of managing the frequency of treatments according to quantitative fecal observations to preserve anthelmintic efficacy.

Background & Problem Statement

• The study focuses on the growing problem of anthelmintic resistance in small strongyles (cyathostomes), a parasite commonly found in horses.
• Resistance to benzimidazole, a type of anthelmintic drug, has increased significantly, affecting more than 50% of the equine population across several European countries.

Discussion on Ivermectin Resistance

• Interestingly, despite widespread use, no indications of resistance to another anthelmintic drug, ivermectin, have been reported.
• This could be due to differences in the mode of action of the drug, or other epidemiological factors which warrant further investigation.

Strategy for Preserving Anthelmintic Efficacy

• The study advises a change in the conventional application of these drugs. Rather than administering treatments at set intervals, the researchers suggest optimizing the frequency of treatments based on quantitative fecal monitoring.
• This approach aims to only administer anthelmintics when absolutely necessary, thereby minimizing drug exposure and reducing the possibility of enhanced drug resistance among the parasite population.

Conclusion

• The alarming rise in anthelmintic resistance among equine parasites necessitates a change in treatment strategies.
• By optimizing anthelmintic application based on quantitative fecal sampling, it is hoped that the remaining effectiveness of these drugs can be better maintained, reducing the speed at which these parasites develop resistance.